Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiol-containing residues, primarily cysteines, in microbial proteins are critical for redox regulation, detoxification, and enzymatic activity. These residues are subject to a variety of modifications including disulfide bond formation, S-glutathionylation, and oxidation to sulfenic, sulfinic, or sulfonic acids. These modifications are often reversible and regulated by cellular reductase systems. Low molecular weight thiols such as glutathione and mycothiol serve as redox buffers, protecting protein thiols from irreversible damage. The reactivity of cysteine residues is influenced by their local protein environment, affecting their susceptibility to modification and subsequent impact on protein function. Targeting these residues offers therapeutic potential but requires careful consideration of potential off-target effects.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiol-Containing Residues in Microbial Proteins (N/A).